Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial

Journal of Cataract and Refractive Surgery

Volumn 33, Issue 11, 2007, Pages 1925-1929

  Duong, Hon Vu Q ^a   Westfield, Kenneth C ^a   Chalkley, Thomas H F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN; KETOROLAC TROMETAMOL; MOXIFLOXACIN; NEPAFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE ACETATE;

ADULT; AGED; ANTERIOR EYE CHAMBER; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT SATISFACTION; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISION;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZENEACETAMIDES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KETOROLAC TROMETHAMINE; LENS CAPSULE, CRYSTALLINE; LENS IMPLANTATION, INTRAOCULAR; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PAIN, POSTOPERATIVE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHACOEMULSIFICATION; PHENYLACETATES; PROSPECTIVE STUDIES; UVEITIS, ANTERIOR; VISUAL ACUITY;

EID: 35448967868     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2007.07.017     Document Type: Article

References (25)

1. Price M.O., and Price F.W. Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery. Curr Med Res Opin 20 (2004) 2015-2019
2. Solomon K.D., Donnenfeld E.D., Raizman M., et al. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients. J Cataract Refract Surg 30 (2004) 1653-1660
3. Lane S.S., Modi S.S., Lehmann R.P., and Holland E.J. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. J Cataract Refract Surg 33 (2007) 53-58 erratum, 563
4. Colin J., and Paquette B. Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial. Clin Ther 28 (2006) 527-536
5. Gamache D.A., Graff G., Brady M.T., et al. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. Inflammation 24 (2000) 357-370
6. Lindstrom R., and Kim T. Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac. Curr Med Res Opin 22 (2006) 397-404 erratum, 1237
7. Waterbury L.D., Silliman D., and Jolas T. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. Curr Med Res Opin 22 (2006) 1133-1140
8. Donnenfeld E.D., Perry H.D., Wittpenn J.R., et al. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg 32 (2006) 1474-1482
9. Ong-Tone L. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery. J Cataract Refract Surg 33 (2007) 59-62
10. Moshirfar M., Feiz V., Vitale A.T., et al. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones; a retrospective observational case series. Ophthalmology 114 (2007) 686-691
11. Burka J.M., Bower K.S., VanRoekel R.C., et al. The effect of moxifloxacin and gatifloxacin on long-term visual outcomes following photorefractive keratectomy. J Refract Surg 23 (2007) 414-417
12. Samudre S.S., Lattanzio Jr. F.A., Williams P.B., and Sheppard Jr. J.D. Comparison of topical steroids for acute anterior uveitis. J Ocul Pharmacol Ther 20 (2004) 533-547
13. Roberts C.W., and Nelson P.L. Comparative analysis of prednisolone acetate suspensions. J Ocul Pharmacol Ther 23 (2007) 182-187
14. Simone J.N., and Whitacre M.M. Effects of anti-inflammatory drugs following cataract extraction. Curr Opin Ophthalmol 12 (2001) 63-67
15. Perry H.D., and Donnenfeld E.D. An update on the use of ophthalmic ketorolac tromethamine 0.4%. Expert Opin Pharmacother 7 (2006) 99-107
16. Saxby L., Rosen E., and Boulton M. Lens epithelial cell proliferation, migration, and metaplasia following capsulorhexis. Br J Ophthalmol 82 (1998) 945-952
17. Sugita M., Kato S., Sugita G., and Oshika T. Migration of lens epithelial cells through haptic root of single-piece acrylic-foldable intraocular lens. Am J Ophthalmol 137 (2004) 377-379
18. Aykan U., Bilge A.H., Karadayi K., and Akin T. The effect of capsulorhexis size on development of posterior capsule opacification: small (4.5 to 5.0 mm) versus large (6.0 to 7.0 mm). Eur J Ophthalmol 13 (2003) 541-545
19. Wejde G., Kugelberg M., and Zetterström C. Position of anterior capsulorhexis and posterior capsule opacification. Acta Ophthalmol Scand 82 (2004) 531-534
20. Heatley C.J., Spalton D.J., Kumar A., et al. Comparison of posterior capsule opacification rates between hydrophilic and hydrophobic single-piece acrylic intraocular lenses. J Cataract Refract Surg 31 (2005) 718-724
21. Sundelin K., Shams H., and Stenevi U. Three-year follow-up of posterior capsule opacification with two different silicone intraocular lenses. Acta Ophthalmol Scand 83 (2005) 11-19
22. Žemaitienė R., Jašinskas V., Barzdžiukas V., and Auffarth G.U. [Prevention of posterior capsule opacification using different intraocular lenses (results of one-year clinical study)]. [Lithuanian] Medicina (Kaunas) 40 (2004) 721-730
23. Sacu S., Findl O., Menapace R., and Buehl W. Influence of optic edge design, optic material, and haptic design on capsular bend configuration. J Cataract Refract Surg 31 (2005) 1888-1894
24. Werner L., Mamalis N., Izak A.M., et al. Posterior capsule opacification in rabbit eyes implanted with 1-piece and 3-piece hydrophobic acrylic intraocular lenses. J Cataract Refract Surg 31 (2005) 805-811
25. Buehl W., Menapace R., Sacu S., et al. Effect of a silicone intraocular lens with a sharp posterior optic edge on posterior capsule opacification. J Cataract Refract Surg 30 (2004) 1661-1667